Drug Profile
Anti-interleukin-5 monoclonal antibody - Wallace Laboratories
Alternative Names: Anti-IL-5 monoclonal antibody - Wallace LaboratoriesLatest Information Update: 08 May 1997
Price :
$50
*
At a glance
- Originator Wallace Laboratories
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Interleukin 5 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 08 May 1997 No-Development-Reported for Asthma in USA (Unknown route)
- 24 Feb 1995 Investigation in Asthma in USA (Unknown route)